Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

Osteoporosis International

Volumn 16, Issue 4, 2005, Pages 403-410

  Siminoski, K ^a   Jiang, G ^b   Adachi, J D ^c   Hanley, D A ^d   Cline, G ^e   Ioannidis, G ^f   Hodsman, A ^g   Josse, R G ^h   Kendler, D ⁱ   Olszynski, W P ^j   Ste Marie, L G ^k   Eastell, R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ST JOSEPH S HOSPITAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^f Charlton Medical Centre   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF SASKATCHEWAN   (Canada)

^k UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Height loss; Osteoporosis; Postmenopausal women; Stature; Vertebral fracture

Indexed keywords

RISEDRONIC ACID;

ACCURACY; AGED; ARTICLE; BODY HEIGHT; CONFIDENCE INTERVAL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MONITORING; MORPHOMETRICS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOGRAPHY; RELIABILITY; RISK; SENSITIVITY AND SPECIFICITY; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; BODY HEIGHT; BONE DENSITY; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPINAL FRACTURES;

EID: 20144388774     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-004-1709-z     Document Type: Article

References (20)

1. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
2. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7:221-227
3. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
4. Lindsay R, Silverman SL, Cooper C et al. (2001) Risk of new vertebral fractures in the year following a fracture. JAMA 285:320-323
5. Nevitt MC, Thompson DE, Black BM et al. (2000) Effect of alendronate on limited activity days and bed disability days caused by back pain in postmenopausal women with existing vertebral fractures. Arch Int Med 160:77-85
6. Adachi JD, Ioannidis G, Berger C et al. (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12:903-908
7. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study. Arch Int Med 159:1215-1220
8. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556-561
9. Ettinger B, Black DM, Nevitt MC et al. (1992) Contribution of vertebral deformities to chronic back pain and disability. J Bone Miner Res 7:449-456
10. Ismail AA, Cooper C, Felsenberg D et al. (1999) Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. Osteoporos Int 9:206-213
11. Kleerekoper M, Nelson DA, Peterson EL, Tilley BC (1992) Outcome variables in osteoporosis trials. Bone 13:S29-S34
12. Huang C, Ross PD, Lydick E, Davis JW, Wasnich RD (1996) Contributions of vertebral fractures to stature loss among elderly Japanese-American women in Hawaii. J Bone Miner Res 11:408-411
13. Davies KM, Recker RR, Stegman MR, Heaney RP (1991) Tallness versus shrinkage: do women shrink with age or grow taller with recent birth date? J Bone Miner Res 6:1115-1120
14. Clinical practice guidelines for the diagnosis and management of osteoporosis (1996) Scientific Advisory Board, Osteoporosis Society of Canada. Can Med Assoc J 155:1113-1129
15. Hodsman AB, Hanley DA, Josse RG (2002) Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Can Med Assoc J 166:1426-1430
16. Reginster J, Minne HW, Sorensen OH et al. (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83-91
17. Harris ST, Watts NB, Genant HK et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344-1352
18. Melton LJ III, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113-119
19. Genant HK, Wu CY, van Kuikj C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148
20. Cline MG, Meredith KE, Boyer JT, Burrows B (1989) Decline of height with age in adults in a general population sample: estimating maximum height and distinguishing birth cohort effects from actual loss of stature with aging. Hum Biol 61:415-425